Lupin's Dapagliflozin Tablets receive US regulatory approval
8 April 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Tuesday that it has received approval from the US Food and Drug Administration (FDA) for it...
M2 Pharma
via M2 Pharma
Updated 2h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
'X-Men' Reboot Director Jake Schreier Says 'Beef' Creator & 'The Bear' Showrunner Are Writing Script For Marvel Film
Next
China Stocks Have Flat Lead For Wednesday
Related Articles
ScienceTraditional TV Ads Are Far Less Effective Than Believed, According to Real-Time Viewership Data
Newswise-14h ago-1 sources
ScienceSF’s Anthropic Unleashes Mythos AI In High-Stakes Project Glasswing Bug Hunt
Hoodline-14h ago-1 sources
ScienceTurmeric and ginger extract may boost implant bonding and kill 92% bacteria
Phys.org-14h ago-1 sources